Key facts
- STE - STERIS plc has 23 insiders with reported activity on this page.
- Net insider value flow over the last year: -$16,659,421.
- Recent transaction rows are available for direct filing-level review.
Insider Transactions Reported by 23 Insiders of STERIS plc
- Symbol
- STE on NYSE
- Location
- Dublin, Ireland
Change
- Buy value: ; sell value: $16,659,420.
- Net share flow: -66,614.
Research use
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsNet insider flow leans to selling over the last 12 months. Net value: -$16,659,421.
Buys
$0
Shares: 0
Insiders: 0
Sells
$16,659,421
Shares: 66,614
Insiders: 7
Net
-$16,659,421
Shares: -66,614
Insiders: -7
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 3,098 | $0 | $734,877 | -$734,877 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 25,203 | $0 | $6,624,685 | -$6,624,685 |
| 9-12 | 0 | 38,313 | $0 | $9,299,859 | -$9,299,859 |
STERIS plc executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Richard C. Breeden | Director | $13,782,370 | Mixed | 13 Aug 2025 | ||
| Daniel A. Carestio | President and CEO, Director | $12,356,034 | -$4,313,788 | -26% | Filing P/S | 06 Oct 2025 |
| Michael J. Tokich | Sr. Vice Pres., CFO | $11,440,139 | Mixed | 04 Jun 2025 | ||
| John Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | $8,926,998 | -$4,454,681 | -33% | Filing P/S | 11 Nov 2025 |
| Jacqueline B. Kosecoff | Director | $7,961,064 | Mixed | 08 Aug 2024 | ||
| Mohsen Sohi | Director | $7,480,046 | -$994,456 | -12% | Mixed | 08 Aug 2025 |
| Cynthia L. Feldmann | Director | $4,232,757 | -$1,579,129 | -27% | Mixed | 05 Mar 2026 |
| Cary L. Majors | SVP and President, Healthcare | $3,241,522 | Mixed | 01 Oct 2025 | ||
| Mary Clare Fraser | SVP & Chief HRO | $3,094,508 | Mixed | 01 Oct 2025 | ||
| Julia Madsen | Sr. VP and GM, Life Sciences | $2,806,020 | -$1,312,096 | -32% | Filing P/S | 21 Nov 2025 |
| Richard Martin Steeves | Director | $2,305,692 | Mixed | 08 Aug 2024 | ||
| Karen L. Burton | Sr. Vice Pres., CFO | $1,994,783 | -$1,909,667 | -49% | Mixed | 01 Oct 2025 |
| David B. Lewis | Director | $1,642,981 | Mixed | 21 Jul 2021 | ||
| Kenneth E. Kohler | Svp & Gm, Ast | $1,640,469 | Mixed | 04 Jun 2025 | ||
| Nirav R. Shah | Director | $1,560,367 | Mixed | 08 Aug 2025 | ||
| Renato Tamaro | V.P. & Corporate Treasurer | $1,467,943 | -$2,095,605 | -59% | Filing P/S | 18 Nov 2025 |
| Andrew Xilas | SVP and GM, Dental | $1,414,619 | Mixed | 31 May 2024 | ||
| Lindsey McGowan | VP, Chf. Comp. & Quality Offc. | $1,337,570 | Mixed | 02 Jan 2026 | ||
| Paul Edward Martin | Director | $1,095,148 | Mixed | 08 Aug 2025 | ||
| Esther M. Alegria | Director | $543,230 | Mixed | 08 Aug 2025 | ||
| Christopher S. Holland | Director | $139,494 | Filing P/S | 08 Aug 2025 | ||
| Louis Shapiro | Director | Mixed | 08 Aug 2025 | |||
| Pierre Boulud | Director | Mixed | 05 May 2026 |
Top shareholders of STERIS plc (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC |
13D/G
13F
|
Vanguard Capital Management · Company |
7.5%
|
7,340,236
|
$1,623,146,387 | $0 | 31 Mar 2026 | |
| STATE STREET CORP |
13D/G
13F
|
STATE STREET CORPORATION · Company |
5.1%
|
4,995,259
|
$1,104,601,623 | $0 | 31 Mar 2026 | |
| VANGUARD PORTFOLIO MANAGEMENT LLC |
13D/G
13F
|
Vanguard Portfolio Management · Company |
5%
|
4,962,018
|
$1,097,251,040 | $0 | 31 Mar 2026 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13D/G
13F
|
Massachusetts Financial Services Company · Company |
4.9%
|
4,846,124
|
$1,199,124,923 | $0 | 30 Sep 2025 | |
| John Adam Zangerle |
3/4/5
|
Sr. VP, Gen Counsel, and Sec. |
0.03%
|
33,669
|
$8,926,998 | -$4,454,681 | 11 Nov 2025 | |
| Julia Madsen |
3/4/5
|
Sr. VP and GM, Life Sciences |
0.01%
|
10,710
|
$2,806,020 | -$1,312,096 | 21 Nov 2025 | |
| Renato Tamaro |
3/4/5
|
V.P. & Corporate Treasurer |
0.01%
|
5,695
|
$1,467,943 | -$2,095,605 | 18 Nov 2025 | |
| Lindsey McGowan |
3/4/5
|
VP, Chf. Comp. & Quality Offc. |
0.01%
|
5,276
|
$1,337,570 | — | 02 Jan 2026 | |
| BlackRock, Inc. |
13F
|
Company |
9.2%
|
9,026,621
|
$1,996,056,667 | — | 31 Mar 2026 | |
| MORGAN STANLEY |
13F
|
Company |
4.5%
|
4,394,263
|
$971,703,958 | — | 31 Mar 2026 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
2.9%
|
2,873,365
|
$635,387,204 | — | 31 Mar 2026 | |
| Orbis Allan Gray Ltd |
13F
|
Company |
2.6%
|
2,592,912
|
$573,370,630 | — | 31 Mar 2026 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.6%
|
2,581,733
|
$568,683,879 | — | 31 Mar 2026 | |
| GENERATION INVESTMENT MANAGEMENT LLP |
13F
|
Company |
2.4%
|
2,308,459
|
$510,469,539 | — | 31 Mar 2026 | |
| Mitsubishi UFJ Asset Management Co., Ltd. |
13F
|
Company |
2.2%
|
2,194,945
|
$485,368,188 | — | 31 Mar 2026 | |
| Select Equity Group, L.P. |
13F
|
Company |
2.2%
|
2,143,379
|
$473,965,398 | — | 31 Mar 2026 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1.9%
|
1,863,139
|
$411,994,872 | — | 31 Mar 2026 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.8%
|
1,763,135
|
$389,883,000 | — | 31 Mar 2026 | |
| Invesco Ltd. |
13F
|
Company |
1.7%
|
1,708,302
|
$377,756,875 | — | 31 Mar 2026 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
1.3%
|
1,253,502
|
$277,186,897 | — | 31 Mar 2026 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.3%
|
1,242,625
|
$274,781,666 | — | 31 Mar 2026 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.1%
|
1,113,845
|
$246,294,766 | — | 31 Mar 2026 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.1%
|
1,061,400
|
$234,707,451 | — | 31 Mar 2026 | |
| BESSEMER GROUP INC |
13F
|
Company |
1.1%
|
1,048,636
|
$231,883,000 | — | 31 Mar 2026 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
1.1%
|
1,029,808
|
$227,707,679 | — | 31 Mar 2026 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.94%
|
922,164
|
$203,918,192 | — | 31 Mar 2026 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.93%
|
908,765
|
$200,955,205 | — | 31 Mar 2026 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.91%
|
890,562
|
$196,931,311 | — | 31 Mar 2026 | |
| Boston Partners |
13F
|
Company |
0.88%
|
862,253
|
$190,664,998 | — | 31 Mar 2026 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.84%
|
823,649
|
$182,108,128 | — | 31 Mar 2026 | |
| Amundi |
13F
|
Individual |
0.79%
|
771,092
|
$170,511,573 | — | 31 Mar 2026 | |
| Legal & General Group Plc |
13F
|
Company |
0.78%
|
764,436
|
$169,039,734 | — | 31 Mar 2026 | |
| Findlay Park Partners LLP |
13F
|
Company |
0.69%
|
674,755
|
$149,208,573 | — | 31 Mar 2026 | |
| LONDON CO OF VIRGINIA |
13F
|
Company |
0.68%
|
670,852
|
$148,346,487 | — | 31 Mar 2026 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.67%
|
656,428
|
$145,155,924 | — | 31 Mar 2026 | |
| CANADA LIFE ASSURANCE Co |
13F
|
Company |
0.62%
|
610,734
|
$135,489,000 | — | 31 Mar 2026 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.6%
|
583,096
|
$128,940,018 | — | 31 Mar 2026 | |
| ROYAL LONDON ASSET MANAGEMENT LTD |
13F
|
Company |
0.57%
|
556,926
|
$123,153,046 | — | 31 Mar 2026 | |
| VANGUARD FIDUCIARY TRUST CO |
13F
|
Company |
0.56%
|
551,989
|
$122,061,328 | — | 31 Mar 2026 | |
| Sustainable Growth Advisers, LP |
13F
|
Company |
0.56%
|
547,179
|
$120,997,693 | — | 31 Mar 2026 | |
| UBS Group AG |
13F
|
Company |
0.56%
|
546,856
|
$120,926,267 | — | 31 Mar 2026 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.54%
|
524,508
|
$115,984,499 | — | 31 Mar 2026 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.53%
|
519,511
|
$114,879,467 | — | 31 Mar 2026 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.5%
|
494,401
|
$125,340,542 | — | 31 Mar 2026 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.49%
|
479,146
|
$105,953,555 | — | 31 Mar 2026 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.45%
|
443,516
|
$97,298,831 | — | 31 Mar 2026 | |
| LOCUST WOOD CAPITAL ADVISERS, LLC |
13F
|
Company |
0.41%
|
397,118
|
$87,814,686 | — | 31 Mar 2026 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.39%
|
381,577
|
$84,378,026 | — | 31 Mar 2026 | |
| Williams Jones Wealth Management, LLC. |
13F
|
Company |
0.39%
|
378,777
|
$83,758,961 | — | 31 Mar 2026 | |
| Nuveen, LLC |
13F
|
Company |
0.38%
|
372,141
|
$82,291,539 | — | 31 Mar 2026 |
Recent Insider Transactions by Companies or Individuals for STERIS plc
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Cynthia L. Feldmann | STE | Ordinary Shares | Sale | -81.5% | $734,877 | $237.21 | -3,098 | 705 | 05 Mar 2026 | Direct |
| Cynthia L. Feldmann | STE | Ordinary Shares | Options Exercise | 439.4% | 3,098 | 3,803 | 05 Mar 2026 | Direct | ||
| Cynthia L. Feldmann | STE | Director Stock Option (right to buy) | Options Exercise | -100% | -3,098 | 0 | 05 Mar 2026 | Direct | ||
| Lindsey McGowan | STE | Ordinary Shares | Award | 18.9% | 798 | 5,028 | 02 Jan 2026 | Direct | ||
| Julia Madsen | STE | Ordinary Shares | Sale | -31.9% | $1,312,096 | $262.00 | -5,008 | 10,710 | 21 Nov 2025 | Direct |
| Julia Madsen | STE | Ordinary Shares | Options Exercise | 58.4% | 5,008 | 13,582 | 21 Nov 2025 | Direct | ||
| Julia Madsen | STE | Employee Stock Option (right to buy) | Options Exercise | -100% | -5,008 | 0 | 21 Nov 2025 | Direct | ||
| Renato Tamaro | STE | Ordinary Shares | Sale | -46.9% | $1,297,040 | $257.55 | -5,036 | 5,695 | 18 Nov 2025 | Direct |
| Renato Tamaro | STE | Ordinary Shares | Options Exercise | 49.2% | 3,536 | 10,731 | 18 Nov 2025 | Direct | ||
| Renato Tamaro | STE | Employee Stock Option (right to buy) | Options Exercise | -100% | -3,536 | 0 | 18 Nov 2025 | Direct | ||
| John Adam Zangerle | STE | Ordinary Shares | Sale | -30.8% | $3,977,100 | $265.14 | -15,000 | 33,669 | 11 Nov 2025 | Direct |
| John Adam Zangerle | STE | Ordinary Shares | Options Exercise | 44.6% | 15,000 | 48,669 | 11 Nov 2025 | Direct | ||
| John Adam Zangerle | STE | Employee Stock Option (right to buy) | Options Exercise | -100% | -15,000 | 0 | 11 Nov 2025 | Direct | ||
| Daniel A. Carestio | STE | Ordinary Shares | Sale | -0.31% | $38,449 | $241.82 | -159 | 51,096 | 06 Oct 2025 | Direct |
| John Adam Zangerle | STE | Ordinary Shares | Tax liability | -0.27% | -91 | 33,669 | 01 Oct 2025 | Direct | ||
| Renato Tamaro | STE | Ordinary Shares | Tax liability | -0.36% | -26 | 7,195 | 01 Oct 2025 | Direct | ||
| Cary L. Majors | STE | Ordinary Shares | Tax liability | -2.21% | -303 | 13,427 | 01 Oct 2025 | Direct | ||
| Julia Madsen | STE | Ordinary Shares | Tax liability | -0.48% | -52 | 10,710 | 01 Oct 2025 | Direct | ||
| Mary Clare Fraser | STE | Ordinary Shares | Tax liability | -1.58% | -207 | 12,882 | 01 Oct 2025 | Direct | ||
| Karen L. Burton | STE | Ordinary Shares | Award | 39.4% | 2,349 | 8,304 | 01 Oct 2025 | Direct | ||
| Karen L. Burton | STE | Ordinary Shares | Tax liability | -0.65% | -39 | 5,955 | 01 Oct 2025 | Direct | ||
| Karen L. Burton | STE | Employee Stock Option (right to buy) | Award | 8,356 | 8,356 | 01 Oct 2025 | Direct | |||
| Daniel A. Carestio | STE | Ordinary Shares | Tax liability | -0.25% | -130 | 51,255 | 01 Oct 2025 | Direct | ||
| Renato Tamaro | STE | Ordinary Shares | Sale | -30.7% | $798,565 | $249.24 | -3,204 | 7,221 | 20 Aug 2025 | Direct |
| Renato Tamaro | STE | Ordinary Shares | Options Exercise | 44.4% | 3,204 | 10,425 | 20 Aug 2025 | Direct | ||
| Renato Tamaro | STE | Employee Stock Option (right to buy) | Options Exercise | -100% | -3,204 | 0 | 20 Aug 2025 | Direct | ||
| Richard C. Breeden | STE | Ordinary Shares | Options Exercise | 12.6% | 4,110 | 36,664 | 13 Aug 2025 | Direct | ||
| Richard C. Breeden | STE | Director Stock Option (right to buy) | Options Exercise | -100% | -4,110 | 0 | 13 Aug 2025 | Direct | ||
| Mohsen Sohi | STE | Ordinary Shares | Sale | -15.5% | $994,456 | $241.96 | -4,110 | 22,361 | 11 Aug 2025 | Direct |
| Mohsen Sohi | STE | Ordinary Shares | Options Exercise | 18.4% | 4,110 | 26,471 | 11 Aug 2025 | Direct | ||
| Mohsen Sohi | STE | Director Stock Option (right to buy) | Options Exercise | -100% | -4,110 | 0 | 11 Aug 2025 | Direct | ||
| Cynthia L. Feldmann | STE | Ordinary Shares | Sale | -83.2% | $844,252 | $241.56 | -3,495 | 705 | 11 Aug 2025 | Direct |
| Cynthia L. Feldmann | STE | Ordinary Shares | Options Exercise | 495.7% | 3,495 | 4,200 | 11 Aug 2025 | Direct | ||
| Cynthia L. Feldmann | STE | Director Stock Option (right to buy) | Options Exercise | -100% | -3,495 | 0 | 11 Aug 2025 | Direct | ||
| Karen L. Burton | STE | Ordinary Shares | Sale | -56.9% | $1,909,667 | $241.73 | -7,900 | 5,994 | 11 Aug 2025 | Direct |
| Karen L. Burton | STE | Ordinary Shares | Options Exercise | 131.8% | 7,900 | 13,894 | 11 Aug 2025 | Direct | ||
| Karen L. Burton | STE | Employee Stock Option (right to buy) | Options Exercise | -100% | -7,900 | 0 | 11 Aug 2025 | Direct | ||
| Mohsen Sohi | STE | Career Restricted Stock Units | Award | 19.8% | 1,278 | 7,750 | 08 Aug 2025 | Direct | ||
| Mohsen Sohi | STE | Director Stock Option (right to buy) | Award | 2,226 | 2,226 | 08 Aug 2025 | Direct | |||
| Louis Shapiro | STE | Career Restricted Stock Units | Award | 975 | 975 | 08 Aug 2025 | Direct | |||
| Nirav R. Shah | STE | Career Restricted Stock Units | Award | 8.1% | 487 | 6,503 | 08 Aug 2025 | Direct | ||
| Nirav R. Shah | STE | Director Stock Option (right to buy) | Award | 1,407 | 1,407 | 08 Aug 2025 | Direct | |||
| Paul Edward Martin | STE | Career Restricted Stock Units | Award | 12% | 487 | 4,562 | 08 Aug 2025 | Direct | ||
| Paul Edward Martin | STE | Director Stock Option (right to buy) | Award | 1,407 | 1,407 | 08 Aug 2025 | Direct | |||
| Christopher S. Holland | STE | Career Restricted Stock Units | Award | 24.4% | 975 | 4,964 | 08 Aug 2025 | Direct | ||
| Cynthia L. Feldmann | STE | Career Restricted Stock Units | Award | 6.37% | 487 | 8,128 | 08 Aug 2025 | Direct | ||
| Cynthia L. Feldmann | STE | Director Stock Option (right to buy) | Award | 1,407 | 1,407 | 08 Aug 2025 | Direct | |||
| Richard C. Breeden | STE | Career Restricted Stock Units | Award | 4.5% | 842 | 19,545 | 08 Aug 2025 | Direct | ||
| Richard C. Breeden | STE | Director Stock Option (right to buy) | Award | 1,704 | 1,704 | 08 Aug 2025 | Direct | |||
| Esther M. Alegria | STE | Career Restricted Stock Units | Award | 20.2% | 487 | 2,896 | 08 Aug 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.